LUMENIS' OPUSDUO ER:YAG RECEIVES FDA CLEARANCE
Lumenis and OpusDent, Lumenis' dental laser division, have announced the FDA clearance of the OpusDuo Er:YAG laser system for contact bone removal during oral surgical and periodontal procedures.
This represents the first FDA clearance for contact cutting of bone tissue in dentistry and is based on the precise and safe Thermal Mechanical Ablation of bone utilizing the company's proprietary contact sapphire tip, the company said.
"FDA clearance for the 'contact cutting' of bone is one of the most significant milestones ever reached in the dental laser field," said Eric Bornstein, who assisted Lumenis with the FDA application. "This will allow practitioners using the OpusDuo to actually feel the laser hand piece make contact with the bony tissues being ablated instead of the previous method of having to point and shoot in a surgical field."